• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

PRESSLED

Your Leading News Source

PRESSLED
Your Leading News Source

  • Home
  • BUSINESS
  • MONEY
  • POLITICS
  • REAL ESTATE
  • US
  • Meet the Reporters
  • About/Contact

New Gene Therapy Partially Restores Sight to Blind Man | Smart News

May 25, 2021 by Staff Reporter

Researchers say they have successfully restored limited vision in a blind man using a new type of gene therapy, reports Tina Hesman Saey of Science News.

The study, published this week in the journal Nature Medicine, used a gene for light-detecting proteins taken from a type of algae to rebuild nerve cells in the man’s eye, reports Jocelyn Kaiser for Science.

“Seeing for the first time that it did work—even if only in one patient and in one eye—is exciting,” Ehud Isacoff, a neuroscientist at the University of California, Berkeley who was not involved in the study, tells Carl Zimmer of the New York Times.

The man’s restored vision can’t be described as full vision, per the Times, as he requires special goggles and still can’t see colors or pick out faces or letters. But where the 58-year-old man, who suffers from a genetic disease called retinitis pigmentosa, could only barely detect light before the procedure, he can now perceive and count objects—even the white stripes of a crosswalk, according to Science News.

“It’s obviously not the end of the road, but it’s a major milestone,” José-Alain Sahel, an ophthalmologist at the University of Pittsburgh and the Sorbonne in Paris and lead author of the study, tells the Times.

The study presents the first instance of the new technique, called optogenetics, successfully being used to treat a human patient, according to Science.

Retinitis pigmentosa, which impacts more than two million people around the world, causes the light-sensitive cells on the surface of the retina to die, reports James Gallagher for BBC News.

To partially restore the man’s sight with optogenetics, researchers inserted the gene that codes for light-sensitive proteins found in algae and bacteria called opsins into the cells at the back of one of his eyes. Opsins change their shape in response to light and microbes use them to inch toward light, according to BBC News.

With the genetic instructions for making opsins inserted into his eye, the researchers were able to repurpose nerve cells in the eye called ganglion cells, which are not normally involved in detecting light, into new light-receptor cells, per the Times.

These new opsins in the man’s eye send electrical signals to his brain when they are exposed to light and subsequently change shape. The catch is that these opsins only respond to amber colored light, which is why the special goggles were necessary, according to BBC News. The goggles are equipped with a camera on the outside and a small video screen on the inside that beams the patterns of light from the outside world to the man’s eye in amber hues. Additionally, the ganglion nerve cells and their new shapeshifting opsins typically respond to changes in light, so the goggles use pulses of light rather than a continuous video to get them to fire, per Science News.

Getting this system to work also required some seven months of training the volunteer’s brain to recognize and make sense of the new signals it was getting. This practice involved wearing the goggles at home and on walks, according to the Times. Around the seven-month mark, the man, who lives in France, excitedly realized he could see the white stripes of a crosswalk.

In lab tests, he was able to correctly count the number of objects set out on a table before him 12 out of 19 times and was able to recognize things such as a book, cups and a bottle of hand sanitizer, according to Science News. Importantly, the man also told researchers the goggles made daily life a bit easier to navigate. Tasks like locating a phone or a plate or perceiving a piece of furniture or a door became possible, according to Science.

Sahel and his collaborators are now seeking to move their technique through clinical trials, according to the Times. Other companies are also hard at work on developing similar methods.

Botond Roska, a neuroscientist and gene therapist at the Institute of Molecular and Clinical Ophthalmology Basel and the University of Basel in Switzerland and co-author of the study, tells Science News that their technique is not a cure for blindness: “For now, all we can say is that there is one patient … with a functional difference.” Still, Sahel tells Science News he believes this clinical result is “a milestone on the road to even better outcomes.”

>>>ad: Don't Miss TODAY'S BEST Amazon Deals!

Originally Appeared Here

Filed Under: TECH/SCIENCE

Primary Sidebar

More to See

Lone Star: Texas Tech Kicker Jonathan Garibay on Dallas Cowboys ‘Opportunity’

The Dallas Cowboys have a vacancy - and just one kicker presently on the roster. And he's a familiar face to Texas Tech fans, as it's Jonathan … [Read More...] about Lone Star: Texas Tech Kicker Jonathan Garibay on Dallas Cowboys ‘Opportunity’

Pan Asia Bank appoints Naleen Edirisinghe as COO – Financial News

Pan Asia Bank recently announced the appointment of Naleen Edirisinghe as its Chief Operating Officer (COO) with effect from 26th April 2022 to take … [Read More...] about Pan Asia Bank appoints Naleen Edirisinghe as COO – Financial News

CRE funds invest billions in U.S. real estate

Multiple commercial real estate funds have poured more than $2.5 billion into the U.S. real estate market in recent weeks, Bisnow reports. These CRE … [Read More...] about CRE funds invest billions in U.S. real estate

Privacy Policy | Terms and Conditions | About/ Contact
Copyright © 2022 · PRESSLED · As Amazon Associates we earn commissions from qualifying purchases · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT